HIT Consultant June 18, 2025
In today’s precision medicine landscape, pharmaceutical companies and access teams face a critical challenge: understanding not just whether therapies work, but how they are accessed, adopted, and experienced by real-world patients. This requires going beyond traditional data sources, particularly claims data, which—while useful—often fails to capture the nuanced clinical and diagnostic steps that define the patient journey. To truly understand and improve therapy adoption, stakeholders need a more complete, context-rich view of real-world care pathways.
The Limits of Traditional Data Sources in Market Access
In precision medicine today, market access isn’t just about generating real-world evidence; it also requires understanding how therapies are adopted across the complex care pathways patients experience in actual clinical practice. From diagnosis to testing to...
Today's Sponsors
Today's Sponsor